Psychiatry and Neurology, Neurology · Chattanooga, TN
NPI
1003261231
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
979 East 3rd Street, Suite C-830
Chattanooga, TN, 37403
Phone (423) 778-9001
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
4,661 services
Medicare patients, 2024
171
Average age 72
Drug cost, 2024
$3.0M
971 prescriptions
Company payments, 2025
$15K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chelsea A Shugars was code G2212 (prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or), 105 times for 14 patients. In total Chelsea A Shugars billed 4,661 services in 44 codes, and Medicare paid $63K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 105 | 14 | $24.33 | $2,555 |
| 95886 Electrical Nerve Conductivity | Office | 75 | 63 | $70.70 | $5,302 |
| 99215 Office E&M - Established | Office | 67 | 39 | $126.00 | $8,442 |
| 95885 Electrical Nerve Conductivity | Office | 56 | 38 | $44.21 | $2,476 |
| 95909 Electrical Nerve Conductivity | Office | 48 | 48 | $96.60 | $4,637 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 48 | 30 | $12.43 | $597 |
| 76883 Ultrasound - Nonspecific | Office | 37 | 26 | $49.89 | $1,846 |
| 99214 Office E&M - Established | Office | 35 | 23 | $88.59 | $3,101 |
| 95910 Electrical Nerve Conductivity | Office | 31 | 31 | $128.40 | $3,980 |
| 99232 Hospital E&M - Subsequent | Facility | 17 | 13 | $58.67 | $997 |
| 95887 Electrical Nerve Conductivity | Office | 16 | 16 | $60.28 | $964 |
| 99205 Office E&M - New | Office | 15 | 15 | $152.89 | $2,293 |
By year: 2022 $31K for 470 services; 2023 $53K for 3,760 services; 2024 $63K for 4,661 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chelsea A Shugars prescribed most often to Medicare patients was Gabapentin, with 137 prescriptions and refills. In total Chelsea A Shugars wrote 971 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 137 | 185 | 37 | $3,540 |
| Prednisone Generic | 74 | 99 | 20 | $381 |
| Radicava Ors Edaravone | 73 | 73 | Under 11 | $1.0M |
| Riluzole Generic | 62 | 112 | 13 | $7,514 |
| Pyridostigmine Bromide Generic | 57 | 98 | 17 | $4,153 |
| Baclofen Generic | 46 | 94 | 13 | $479 |
| Mycophenolate Mofetil Generic | 40 | 56 | Under 11 | $7,321 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 37 | 37 | Under 11 | $201K |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 36 | 36 | Under 11 | $292K |
| Duloxetine Hcl Generic | 31 | 49 | Under 11 | $406 |
| Pregabalin Generic | 27 | 27 | Under 11 | $389 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 26 | 26 | Under 11 | $413K |
| Sodium Chloride 0.9 % Sodium Chloride | 24 | 24 | Under 11 | $243 |
| Azathioprine Generic | 16 | 19 | Under 11 | $492 |
| Donepezil Hcl Generic | 15 | 15 | Under 11 | $26.75 |
Brand drugs: - claims; generic drugs: 714 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chelsea A Shugars $15K ($15K in general payments such as food, travel and fees) from 28 companies. The largest payer was Natus Medical Incorporated with $6,821.
| Company | Payments | Amount |
|---|---|---|
| Natus Medical Incorporated | 1 | $6,821 |
| Tanabe Pharma America, Inc. | 12 | $5,632 |
| Abbvie Inc. ABBV | 28 | $424 |
| Argenx US, Inc. ARGX | 5 | $276 |
| UCB, Inc. UCB.BR | 3 | $190 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $165 |
| ACADIA Pharmaceuticals Inc ACAD | 7 | $138 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $103 |
| Pfizer Inc. PFE | 4 | $79.47 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $73.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.